Literature DB >> 12134040

Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.

David Lim1, Marianna Orlova, Stephen P Goff.   

Abstract

Both the RNase H domain of Moloney murine leukemia virus (Mo-MLV) reverse transcriptase (RT) and Escherichia coli RNase H possess a positively charged alpha-helix (C helix) and a loop that are not present in the RNase H domains of human immunodeficiency virus (HIV) RT or avian sarcoma virus RT. Although a mutant Mo-MLV RT lacking the C helix (DeltaC RT) retains DNA polymerase activity on homopolymeric substrates and partial RNase H activity, reverse transcription of the viral RNA genome in vivo is defective. To identify the essential features of the C helix, a panel of Mo-MLV RT mutants was generated. Analyses of these mutant viruses revealed the importance of residues H594, I597, R601, and G602. The mutants were tested for their ability to synthesize viral DNA after acute infections and to form proper 5' and 3' viral DNA ends. The mutant RTs were tested in vitro for exogenous RT activity, minus-strand strong-stop DNA synthesis in endogenous RT reactions, nonspecific RNase H activity, and finally, proper cleavage at the polypurine tract-U3 junction. The R601A mutant was the most defective mutant both in vivo and in vitro and possessed very little RNase H activity. The H594A, I597A, and G602A mutants had significant reductions in RNase H activity and in their rates of viral replication. Many of the mutants formed improper viral DNA ends and were less efficient in PPT-U3 recognition and cleavage in vitro. The data show that the C helix plays a crucial role for overall RNase H cleavage activity. The data also suggest that the C helix may play an important role in polypurine tract recognition and proper formation of the plus-strand DNA's 5' end.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12134040      PMCID: PMC155118          DOI: 10.1128/jvi.76.16.8360-8373.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.

Authors:  C M Smith; W B Potts; J S Smith; M J Roth
Journal:  Virology       Date:  1997-03-17       Impact factor: 3.616

3.  Domain structure of the Moloney murine leukemia virus reverse transcriptase: mutational analysis and separate expression of the DNA polymerase and RNase H activities.

Authors:  N Tanese; S P Goff
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

4.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

5.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

7.  Three-dimensional structure of ribonuclease H from E. coli.

Authors:  K Katayanagi; M Miyagawa; M Matsushima; M Ishikawa; S Kanaya; M Ikehara; T Matsuzaki; K Morikawa
Journal:  Nature       Date:  1990-09-20       Impact factor: 49.962

8.  Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 A resolution shows bent DNA.

Authors:  A Jacobo-Molina; J Ding; R G Nanni; A D Clark; X Lu; C Tantillo; R L Williams; G Kamer; A L Ferris; P Clark
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Incomplete removal of the RNA primer for minus-strand DNA synthesis by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  K A Pullen; L K Ishimoto; J J Champoux
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

10.  Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  S J Stahl; J D Kaufman; S Vikić-Topić; R J Crouch; P T Wingfield
Journal:  Protein Eng       Date:  1994-09
View more
  20 in total

1.  Specific recognition and cleavage of the plus-strand primer by reverse transcriptase.

Authors:  Angela Atwood-Moore; Kenechi Ejebe; Henry L Levin
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  A structure-based mechanism for tRNA and retroviral RNA remodelling during primer annealing.

Authors:  Sarah B Miller; F Zehra Yildiz; Jennifer A Lo; Bo Wang; Victoria M D'Souza
Journal:  Nature       Date:  2014-09-07       Impact factor: 49.962

3.  Crystal structure of the moloney murine leukemia virus RNase H domain.

Authors:  David Lim; G Glenn Gregorio; Craig Bingman; Erik Martinez-Hackert; Wayne A Hendrickson; Stephen P Goff
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores.

Authors:  Marcy R Auerbach; Kristy R Brown; Artem Kaplan; Denise de Las Nueces; Ila R Singh
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 5.  Murine leukemia virus reverse transcriptase: structural comparison with HIV-1 reverse transcriptase.

Authors:  Marie L Coté; Monica J Roth
Journal:  Virus Res       Date:  2008-02-21       Impact factor: 3.303

6.  Mutation of amino acids in the connection domain of human immunodeficiency virus type 1 reverse transcriptase that contact the template-primer affects RNase H activity.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

7.  Functional characterization of a portion of the Moloney murine leukemia virus gag gene by genetic footprinting.

Authors:  Marcy R Auerbach; Chang Shu; Artem Kaplan; Ila R Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

8.  Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.

Authors:  Marcy R Auerbach; Kristy R Brown; Ila R Singh
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

Review 9.  Ribonuclease H: properties, substrate specificity and roles in retroviral reverse transcription.

Authors:  James J Champoux; Sharon J Schultz
Journal:  FEBS J       Date:  2009-02-18       Impact factor: 5.542

10.  Substitution of alanine for tyrosine-64 in the fingers subdomain of M-MuLV reverse transcriptase impairs strand displacement synthesis and blocks viral replication in vivo.

Authors:  Benjamin A Paulson; Miaohua Zhang; Sharon J Schultz; James J Champoux
Journal:  Virology       Date:  2007-05-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.